PHASEBIO PHARMACEUTICALS INC (PHASQ)
Institutional ownership reported to the SEC as of Q4 2022, across 17 quarters.
3
Reporting holders
$10.6K
Reported value
0.0%
Held as options
-26
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| DAFNA Capital Management LLC | $9.7K | 321,856 | 0.00% | 17q | HELD |
| IPG Investment Advisors LLC | $864 | 28,700 | 0.00% | 5q | HELD |
| BARCLAYS PLC | $6 | 197 | 0.00% | new | NEW |
| ACADIAN ASSET MANAGEMENT LLC | $4 | 172,958 | 0.00% | 6q | HELD |
| HAMILTON LANE ADVISORS LLC | $1 | 34,208 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2022 | 3 | $10.6K | 350,753 | 1 | 0 | 0 | 0.0% |
| Q3 2022 | 29 | $3.9M | 22,136,588 | 0 | 4 | 12 | 0.0% |
| Q2 2022 | 43 | $14.0M | 23,398,123 | 7 | 7 | 10 | 0.0% |
| Q1 2022 | 54 | $38.9M | 29,391,391 | 12 | 8 | 15 | 0.3% |
| Q4 2021 | 50 | $75.0M | 28,442,540 | 8 | 16 | 12 | 1.0% |
| Q3 2021 | 59 | $96.1M | 30,813,516 | 12 | 21 | 12 | 0.3% |
| Q2 2021 | 53 | $113.3M | 30,418,407 | 13 | 13 | 18 | 0.1% |
| Q1 2021 | 61 | $110.6M | 31,843,034 | 10 | 20 | 17 | 0.4% |
| Q4 2020 | 56 | $53.5M | 15,810,909 | 12 | 16 | 15 | 0.8% |
| Q3 2020 | 50 | $60.2M | 17,130,049 | 3 | 17 | 14 | 0.1% |
| Q2 2020 | 61 | $84.5M | 18,335,445 | 22 | 18 | 11 | 0.2% |
| Q1 2020 | 48 | $61.1M | 18,472,249 | 7 | 14 | 16 | 0.0% |
| Q4 2019 | 50 | $119.6M | 19,585,340 | 8 | 14 | 16 | 0.0% |
| Q3 2019 | 58 | $77.3M | 18,536,887 | 13 | 20 | 11 | 0.0% |
| Q2 2019 | 51 | $245.2M | 18,763,700 | 35 | 15 | 1 | 0.0% |
| Q1 2019 | 19 | $65.8M | 6,922,693 | 9 | 5 | 3 | 0.0% |
| Q4 2018 | 15 | $21.2M | 6,874,937 | 2 | 0 | 0 | 0.0% |